Full-Time

Business Systems Analyst

Confirmed live in the last 24 hours

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Biotechnology
Healthcare

Compensation Overview

CA$77.8k - CA$97.2kAnnually

+ Equity + Annual Bonus

Senior

Vancouver, BC, Canada

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Python
Coupa
Data Analysis
Requirements
  • 5+ years’ experience as a Business Systems Analyst, Application Analyst, Software Developer, or in a related role
  • Bachelor’s Degree in a relevant field (e.g. Computer Science, Mathematics, Statistics, or Economics)
  • Technical experience configuring and maintaining SAP S4/HANA for Finance and/or Manufacturing
  • Experience supporting and maintaining other SAP products, such as SAP Integration Suite, SAP Analytics Cloud, or Signavio would be desirable
  • Significant experience working cross-functionally in a highly collaborative environment
  • Experience evaluating, documenting, and testing business requirements against newly developed features and capabilities
  • Previous experience or an interest in the Biotechnology, Pharma, or Life Sciences industries
  • Experience with or exposure to a GMP or SOX regulated organization would be an asset
  • Familiarity or previous experience with spend management applications such as Coupa or Ariba
  • Experience with Analytics, Business Intelligence, ETL, or Data Warehousing tools and practices
  • Familiarity or previous experience developing or maintaining applications integrations, with Dell Boomi being a desirable asset
  • Experience in one or more programming languages, preferably Python
Responsibilities
  • Working as part of a nimble team to configure and maintain AbCellera’s business applications including ERP (SAP S/4HANA), Procurement (Coupa), Integration (Boomi), and Planning/Forecasting (SAP Analytics Cloud) business applications
  • Partnering with IT & business teams to design, implement, and integrate new capabilities and functionality within our Business Applications suite
  • Acting as a subject matter expert, evaluating and driving improvements to business-critical processes and data through our cross-functional architecture group
  • Embedding into cross-functional project teams as a technical expert to support the full lifecycle of software implementation
  • Partnering with business data owners to investigate and remediate data quality issues; taking ownership for process and system improvements to prevent repeat events
  • Planning, testing, and executing system updates to maintain system availability and enable new capabilities
  • Collaborating with audit & quality teams to evaluate, test, and maintain business applications to meet our compliance needs

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

Grant

Total Funding

$620.9M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

5%

1 year growth

0%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaborations with firms like Viking Global Investors and Biogen expand AbCellera's capabilities and market opportunities.
  • AbCellera's participation in high-profile industry conferences and presentations, such as AACR, showcases its cutting-edge research and strengthens its industry reputation.
  • The company's internal pipeline of therapeutic programs offers potential for significant breakthroughs and new treatments.

What critics are saying

  • The highly competitive and rapidly evolving biopharmaceutical market requires continuous innovation to maintain a competitive edge.
  • The recent resignation of board member Peter Thiel could lead to strategic and governance challenges.

What makes AbCellera Biologics unique

  • AbCellera's proprietary technology platform accelerates antibody discovery, making it faster and more efficient than traditional methods.
  • The company's ability to tackle challenging targets that have been difficult to address with traditional methods sets it apart in the biopharmaceutical market.
  • AbCellera's collaborative business model, which includes partnerships with leading investment firms and biotech companies, enhances its innovation and market reach.

Help us improve and share your feedback! Did you find this helpful?